Results 151 to 160 of about 63,834 (278)

Visceral adiposity and insulin resistance in polycystic ovarian syndrome - A cross-sectional, observational study. [PDF]

open access: yesEur J Obstet Gynecol Reprod Biol X
Sridharan A   +7 more
europepmc   +1 more source

Efficacy of Weight‐Lowering Agents on Fat Distribution: A Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials

open access: yesObesity Reviews, EarlyView.
ABSTRACT Background Pharmacotherapy offers a potential solution for individuals with overweight and obesity to decrease their body weight. However, there is limited knowledge of the effects of antiobesity agents on the distribution of body fat. Methods The PubMed, Embase, and Cochrane Library databases were reviewed for randomized controlled trials ...
Xiuqi Qiao   +4 more
wiley   +1 more source

A Systematic Review and Meta‐Analysis of Semaglutide Effects on Adipose Tissue and Emerging Effects on Brain and Cognition

open access: yesObesity Reviews, EarlyView.
ABSTRACT Background In 2023 and 2024, research into semaglutide (SEMA), an antiobesity and antidiabetic medication, indicated potential benefits beyond its approved uses, particularly in preventing Alzheimer's disease (AD). This highlights the link between obesity and AD development.
Amene Saghazadeh   +14 more
wiley   +1 more source

Prediction of exposure to pollutants and hormones on the risk of polycystic ovarian syndrome. [PDF]

open access: yesJ Ovarian Res
Hou W   +7 more
europepmc   +1 more source

Low Weight Loss Response to Incretin Analogs: A Systematic Review

open access: yesObesity Reviews, EarlyView.
ABSTRACT The development of GLP‐1 and GIP analogs has been a significant breakthrough in type 2 diabetes and obesity pharmacotherapy. However, individual responses to these medications can vary widely. This systematic review examines factors associated with low or no weight loss response to GLP‐1 and GIP analogs. Key predictors of poor response include
Pamela S. Gaskin, Peter S. Chami
wiley   +1 more source

Variations in serum ferritin levels in women with polycystic ovarian syndrome undergoing assisted reproduction. [PDF]

open access: yesJ Taibah Univ Med Sci
Vikhnan D   +8 more
europepmc   +1 more source

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms

open access: yesObesity Reviews, EarlyView.
ABSTRACT GLP‐1 receptor agonist medications have the potential to promote marked weight loss, but maximal and sustained benefit may be compromised by poor compliance and cessation of use. Development of next‐generation medications that address current obstacles to effective use and development of effective adjunct treatments will benefit from better ...
Giorgia Rutigliani   +8 more
wiley   +1 more source

Analysis of Laparoscopic and Transvaginal Ovarian Drilling on Polycystic Ovarian Syndrome: A Narrative Review of Outcomes. [PDF]

open access: yesCureus
Rukh Afzal M   +7 more
europepmc   +1 more source

Racial Differences in Dermatologic Treatment for Adolescents With PCOS‐Related Acne Vulgaris

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background/Objectives Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women, with acne frequently appearing during adolescence. Racial and ethnic disparities in PCOS phenotype and adult acne treatment are well documented, yet differences in acne management among adolescents with PCOS remain unclear.
Samantha Garcia, Brandi Kenner‐Bell
wiley   +1 more source

Next-generation Approaches in Targeting Polycystic Ovarian Syndrome: Innovative Strategies. [PDF]

open access: yesCurr Med Chem
Narayanan PL   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy